You just read:

Biohaven's Verdiperstat Receives FDA May Proceed Letter To Initiate Trial In Amyotrophic Lateral Sclerosis Conducted By The Healey Center For ALS At Mass General

News provided by

Biohaven Pharmaceutical Holding Company Ltd.

Jan 22, 2020, 16:15 ET